Epidermal growth factor receptor targeting in head and neck cancer: have we been just skimming the surface?

Abstract

Despite extensive research in squamous cell carcinoma of the head and neck (SCCHN), the epidermal growth factor receptor (EGFR) remains the only nonchemotherapeutic molecular target that has been successfully translated into a biologic therapy with clinical benefit. Targeting this transmembrane tyrosine kinase growth factor receptor in SCCHN is an… (More)
DOI: 10.1200/JCO.2012.47.9220

Topics

Cite this paper

@article{Hansen2013EpidermalGF, title={Epidermal growth factor receptor targeting in head and neck cancer: have we been just skimming the surface?}, author={Aaron R Hansen and Lillian L. Siu}, journal={Journal of clinical oncology : official journal of the American Society of Clinical Oncology}, year={2013}, volume={31 11}, pages={1381-3} }